Home Tags Lancet
Carried out by an international team of researchers from the UK and European nations including Spain and Austria, the study involved 582 patients aged 3 to 18 years.
The anti-malarial drug HCQ was left out of the WHO Solidarity trial and the USFDA emergency use list this week. Doctors in India say they don’t see any major side-effects from its use.
The danger now is that if a severe flare-up in Covid infections were to strike, we would still lack clear evidence of any existing, cheap treatment.
‘The Lancet’ retracted a key study that linked anti-malarial drug HCQ to increased risk of death and irregularity in heart rhythms in coronavirus patients.
Mandeep R. Mehra, who graduated from a medical college in Maharashtra, is now a professor at Harvard, while Sapan S. Desai founded the data analytics firm Surgisphere.
In episode 489 of #CutTheClutter, Shekhar Gupta discusses the controversial studies that were retracted after scientists around the world raised questions on its data accuracy.
Three of the four authors of the study apologised to The Lancet's editors and readership for any embarrassment or inconvenience their published findings may have caused.
Questions have been raised on the Lancet HCQ study over dataset and methodology. Another journal has issued similar concern over a study that used same data.
More than a hundred scientists have raised questions about the dataset used in the study published by The Lancet, which led to WHO halting all trials of HCQ.
From potential vaccines to chat bot help, ThePrint brings you the top developments on the coronavirus pandemic from across the world.